NGEN (NervGen Pharma) Short Ratio


NGEN NervGen Pharma Corp NGEN
22 GF Score
Price $2.10
! 2 Warning Signs
View Full Analysis

What is NervGen Pharma Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NGEN
22GF Score
NervGen Pharma Corp NGEN
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NervGen Pharma Business Description

Other Exchanges 9UA:Germany
Address 112-970 Burrard Street, Unit 1290, Vancouver, BC, CAN, V6Z 2R4
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
22GF Score

Get the complete analysis for NGEN

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.10
Price